HUALAN BIOLOGICAL(SZ:002007) Xin Lang Cai Jing·2025-08-28 10:43Group 1 - Core viewpoint: Hualan Biological (002007.SZ) reported its semi-annual results for 2025, revealing significant institutional investor interest with 29 institutions holding a total of 660 million shares, representing 36.12% of the total share capital [1] - The top ten institutional investors collectively hold 36.05% of Hualan Biological's shares, with a slight decrease of 1.14 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, one fund, the Biological Vaccine ETF, increased its holdings, while two funds, including the Innovative Medicine and the China Securities Index Fund, saw a reduction in holdings by 0.26% [2] - A total of 14 new public funds were disclosed this period, including Southern CSI 500 ETF and Ping An CSI A500 ETF, while 9 funds were no longer disclosed, such as E Fund CSI 300 Medical ETF and Huatai-PineBridge CSI 300 ETF [2] - Foreign investment sentiment showed an increase in holdings from one foreign fund, Hong Kong Central Clearing Limited, with an increase of 0.32% [2]